Northwestern Mutual Wealth Management’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-850
Closed -$109K 3830
2025
Q2
$109K Sell
850
-19
-2% -$1.97K ﹤0.01% 1970
2025
Q1
$76.9K Buy
869
+15
+2% +$1.46K ﹤0.01% 2028
2024
Q4
$74.5K Sell
854
-45
-5% -$4.12K ﹤0.01% 2028
2024
Q3
$83.2K Buy
899
+18
+2% +$1.79K ﹤0.01% 1972
2024
Q2
$95K Hold
881
﹤0.01% 1849
2024
Q1
$83.6K Hold
881
﹤0.01% 1891
2023
Q4
$81.3K Buy
881
+31
+4% +$2.01K ﹤0.01% 1862
2023
Q3
$42.7K Hold
850
﹤0.01% 2026
2023
Q2
$53.7K Hold
850
﹤0.01% 1955
2023
Q1
$38.2K Hold
850
﹤0.01% 2041
2022
Q4
$37.2K Hold
850
﹤0.01% 2013
2022
Q3
$56K Hold
850
﹤0.01% 1862
2022
Q2
$43K Buy
850
+746
+717% +$43.7K ﹤0.01% 1971
2022
Q1
$6K Buy
104
+4
+4% +$287 ﹤0.01% 2670
2021
Q4
$11K Hold
100
﹤0.01% 2533
2021
Q3
$10K Hold
100
﹤0.01% 2455
2021
Q2
$9K Hold
100
﹤0.01% 2457
2021
Q1
$10K Buy
+100
New +$9.98K ﹤0.01% 2275
2019
Q2
Sell
-2
Closed 2511
2019
Q1
$0 Buy
+2
New +$148 ﹤0.01% 2536

Other funds holding BPMC

Northwestern Mutual Wealth Management's BPMC Position: Q3 2025 in Review

Northwestern Mutual Wealth Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 850 shares — an estimated $109K sold.

Northwestern Mutual Wealth Management first reported a position in BPMC in Q1 2019 and held it in 19 quarters. The position peaked at $109K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Northwestern Mutual Wealth Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 850 Blueprint Medicines shares in Q3 2025, an estimated $109K.
  • Northwestern Mutual Wealth Management first reported a position in Blueprint Medicines in Q1 2019 and held it in 19 quarters.
  • Northwestern Mutual Wealth Management's Blueprint Medicines position peaked at $109K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.